Your browser doesn't support javascript.
loading
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
Lophatananon, Artitaya; Stewart-Brown, Sarah; Kote-Jarai, Zsofia; Olama, Ali Amin Al; Garcia, Sara Benlloch; Neal, David E; Hamdy, Freddie C; Donovan, Jenny L; Giles, Graham G; Fitzgerald, Liesel M; Southey, Melissa C; Pharoah, Paul; Pashayan, Nora; Gronberg, Henrik; Wiklund, Fredrik; Aly, Markus; Stanford, Janet L; Brenner, Hermann; Dieffenbach, Aida K; Arndt, Volker; Park, Jong Y; Lin, Hui-Yi; Sellers, Thomas; Slavov, Chavdar; Kaneva, Radka; Mitev, Vanio; Batra, Jyotsna; Spurdle, Amanda; Clements, Judith A; Easton, Douglas; Eeles, Rosalind A; Muir, Kenneth.
Afiliación
  • Lophatananon A; Centre of Epidemiology, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
  • Stewart-Brown S; Division of Health sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
  • Kote-Jarai Z; Centre of Epidemiology, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
  • Olama AAA; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.
  • Garcia SB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
  • Neal DE; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
  • Hamdy FC; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.
  • Donovan JL; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
  • Giles GG; Nuffield Department of Surgical Sciences John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Fitzgerald LM; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
  • Southey MC; Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, Victoria 3004, Australia.
  • Pharoah P; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia.
  • Pashayan N; Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, Victoria 3004, Australia.
  • Gronberg H; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia.
  • Wiklund F; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
  • Aly M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
  • Stanford JL; Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
  • Brenner H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm 10435, Sweden.
  • Dieffenbach AK; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm 10435, Sweden.
  • Arndt V; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm 10435, Sweden.
  • Park JY; Department of Clinical Sciences at Danderyds Hospital, Stockholm 17177, Sweden.
  • Lin HY; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
  • Sellers T; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA.
  • Slavov C; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Kaneva R; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Mitev V; German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
  • Batra J; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
  • Spurdle A; German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
  • Clements JA; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
  • Easton D; Department of Urology and Alexandrovska University Hospital, Medical University, Sofia 1431, Bulgaria.
  • Eeles RA; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University, Sofia, 2 Zdrave Str., Sofia 1431, Bulgaria.
  • Muir K; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University, Sofia, 2 Zdrave Str., Sofia 1431, Bulgaria.
Br J Cancer ; 117(5): 734-743, 2017 Aug 22.
Article en En | MEDLINE | ID: mdl-28765617

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Estatura Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Estatura Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido